GPC5 and metabolic dysfunction-associated steatotic liver disease: Simpson-Golabi-Behmel syndrome (overgrowth) (GPC3-4) (98); GPC4 (serum, AT) increases with BMI, insulin resistance, NAFLD (100–106); GPC5 risk allele in DKD (107)